Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presented its investor deck in February 2022 detailing innovations in treating diuretic-resistant fluid overload. The presentation covers the alfapump® system for refractory ascites and DSR® therapy, both addressing critical unmet needs in fluid management.
conference
21 Pages
investor_presentation
26 Pages
Recro Pharma
ATS Automation Investor Presentation June 2021
investor_presentationinvestor_presentation
22 Pages
ATS Automation Tooling Systems